Debra Kelsh

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang et al. · Journal of Psychopharmacology · 2018 · 183 citations · Full text

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder

Sharon Walsh, Sandra D. Comer, Michelle R. Lofwall et al. · JAMA Psychiatry · 2017 · 75 citations · Full text

Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem

Mike Ufer, Debra Kelsh, Kerri A. Schoedel et al. · SLEEP · 2021 · 42 citations · Full text

A randomized, double‐blind, placebo‐controlled study of the kappa opioid receptor antagonist, CERC‐501, in a human laboratory model of smoking behavior

Jermaine D. Jones, Shanna Babalonis, Ronald N. Marcus et al. · Addiction Biology · 2019 · 23 citations · Full text

Tobacco Cessation, Substance Use, Nicotine Withdrawal +22

Abuse potential of mirogabalin in recreational polydrug users

Jeanne Mendell, Naama Levy‐Cooperman, Ed Sellers et al. · Therapeutic Advances in Drug Safety · 2019 · 18 citations · Full text